Alan Scott Enterprises Ltd
Incorporated in 1994, Alan Scott Industries manufacture health and hygiene products for use in hospitals and homes
- Market Cap ₹ 155 Cr.
- Current Price ₹ 271
- High / Low ₹ 404 / 94.0
- Stock P/E
- Book Value ₹ 19.7
- Dividend Yield 0.00 %
- ROCE -14.1 %
- ROE -45.8 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 13.8 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -88.7% over last 3 years.
- Earnings include an other income of Rs.1.16 Cr.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 0.02 | 1.24 | 5.17 | 11.42 | 28.69 | 34.35 | |
| 0.11 | 1.90 | 5.60 | 11.47 | 26.75 | 33.63 | |
| Operating Profit | -0.09 | -0.66 | -0.43 | -0.05 | 1.94 | 0.72 |
| OPM % | -450.00% | -53.23% | -8.32% | -0.44% | 6.76% | 2.10% |
| 0.09 | 0.67 | 0.06 | 0.35 | 2.25 | 1.16 | |
| Interest | 0.00 | 0.02 | 0.61 | 1.38 | 2.20 | 2.29 |
| Depreciation | 0.00 | 0.05 | 1.08 | 2.41 | 3.80 | 4.06 |
| Profit before tax | 0.00 | -0.06 | -2.06 | -3.49 | -1.81 | -4.47 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | -2.68% | |
| 0.00 | -0.07 | -2.06 | -3.50 | -1.82 | -4.30 | |
| EPS in Rs | 0.00 | -0.11 | -3.50 | -6.48 | -3.37 | -5.21 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 344% |
| 3 Years: | 88% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -32% |
| TTM: | 18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 46% |
| 5 Years: | 82% |
| 3 Years: | 97% |
| 1 Year: | 136% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -79% |
| 3 Years: | -89% |
| Last Year: | -46% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 1.19 | 1.83 | 1.83 | 3.62 | 3.63 | 5.72 |
| Reserves | 0.35 | 1.25 | -0.64 | -0.26 | -1.86 | 5.53 |
| 0.05 | 0.17 | 3.00 | 8.62 | 7.38 | 9.65 | |
| 0.00 | 2.32 | 6.20 | 15.87 | 18.10 | 14.96 | |
| Total Liabilities | 1.59 | 5.57 | 10.39 | 27.85 | 27.25 | 35.86 |
| 0.00 | 2.60 | 6.01 | 15.03 | 15.82 | 15.59 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.52 |
| Investments | 0.30 | 0.21 | 0.21 | 0.89 | 1.36 | 2.09 |
| 1.29 | 2.76 | 4.17 | 11.93 | 10.07 | 14.66 | |
| Total Assets | 1.59 | 5.57 | 10.39 | 27.85 | 27.25 | 35.86 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 0.18 | -1.58 | -2.78 | -3.11 | -1.68 | -6.16 | |
| -0.21 | -0.95 | 0.31 | -3.05 | 0.10 | -5.64 | |
| 1.29 | 1.73 | 2.15 | 8.53 | -0.15 | 12.63 | |
| Net Cash Flow | 1.26 | -0.80 | -0.33 | 2.37 | -1.74 | 0.84 |
| Free Cash Flow | 0.18 | -2.15 | -3.47 | -5.48 | -2.47 | -11.92 |
| CFO/OP | -200% | 239% | 647% | 6,240% | -87% | -856% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 2.94 | 0.71 | 13.10 | 7.89 | 6.48 |
| Inventory Days | 124.03 | 227.11 | 211.75 | 88.66 | 119.15 | |
| Days Payable | 88.59 | 107.76 | 126.84 | 15.87 | 18.84 | |
| Cash Conversion Cycle | 0.00 | 38.38 | 120.06 | 98.01 | 80.68 | 106.79 |
| Working Capital Days | -730.00 | 73.59 | -46.60 | -70.63 | 26.33 | 53.13 |
| ROCE % | -27.63% | -35.79% | -26.39% | -14.21% | -14.14% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Total Employee Headcount Number |
|
|||||
| Number of Miniso Franchise Stores Number |
||||||
| Number of XTEP Franchise Stores Number |
||||||
| Number of Identified Worker Roles (UpnUp Platform) Number |
||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
29 May - Alan Scott Enterprises reported FY26 total income of ₹35.51 Cr, EBITDA ₹1.88 Cr, up 14.77% YoY.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
27 May - We are pleased to submit herewith a presentation providing a comprehensive overview of Alan Scott Enterprises Ltd and its subsidiaries. The enclosed document captures our …
-
Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended March 31, 2026.
27 May - Reports no deviation in use of ₹6.75 crore preferential issue proceeds for quarter ended March 31, 2026.
-
Submission Of Audited Standalone And Consolidated Financial Results And Report Of The Auditors As Per Regulation 33 Of SEBI (Listing Obligations And Disclosures Requirements), Regulations 2015 For The Quarter And Year Ended March 31, 2026.
27 May - Alan Scott Enterprises approved FY26 audited results; standalone loss ₹7.97 lakh, consolidated loss ₹447.34 lakh.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, May 27, 2026.
27 May - Board approved FY26 audited results and rights issue up to 9,52,932 shares for Rs7.15 crore, ratio 1:6.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2012
from bse
-
Financial Year 2006
from bse
-
Financial Year 2005
from bse
Product Profile:
a) 5 petals AIR purifier+[1]
This uses 8 different technologies instead of 5 certified technologies to provide protection from aerosol spread of 99.9% of Virus, Bacteria, fungus and Yeasts
b) 5 Petals O2 Concentrator[2]
It's a supplement of oxygen with a capacity
of 8-25 LPM and a High Purity Oxygen 90-95%
Clientele:[3]
Larsen & Tubro, Som Capital, Rubix,
Thought Bridge HR, Verstech, Sunicon, Sanjivani Parentrals3